FP 016
Alternative Names: FP-016Latest Information Update: 06 Nov 2023
At a glance
- Originator Foresee Pharmaceuticals
- Class Antipsychotics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Neurological disorders
Most Recent Events
- 10 Oct 2023 Preclinical trials in Neurological disorders in USA (unspecified route)